Prevention and Treatment of Sarcopenia
Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of f...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_76517 | ||
005 | 20220111 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-1535-9 | ||
020 | |a 9783036515366 | ||
020 | |a 9783036515359 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-1535-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Testa, Gianluca |4 edt | |
700 | 1 | |a Testa, Gianluca |4 oth | |
245 | 1 | 0 | |a Prevention and Treatment of Sarcopenia |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (288 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Sarcopenia represents the decline in skeletal muscle mass and function with age, characterized by the muscle fiber's quality, strength, muscle endurance, and metabolic ability decreasing, as well as the fat and connective tissue growing.Reduction of muscle strength with aging leads to loss of functional capacity, causing disability, mortality, and other adverse health outcomes. Because of the increase of the proportion of elderly in the population, sarcopenia-related morbidity will become an increasing area of health care resource utilization.Diagnostic screening consists of individuation of body composition, assessed by DEXA, anthropometry, bioelectrical impedance, MRI, or CT scan. Management is possible with resistance training exercise and vibration therapy, nutritional supplements, and pharmacological treatment.The book includes articles from different nationalities, treating the experimental and medical applications of sarcopenia. The consequences of sarcopenia in frailty are treated in relation to other associated pathologies or lesions, as femoral neck fractures and hepatocellular carcinoma. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a muscle-mass | ||
653 | |a sleep efficiency | ||
653 | |a sleep duration | ||
653 | |a insomnia | ||
653 | |a sarcopenia | ||
653 | |a quality of life | ||
653 | |a osteoporosis | ||
653 | |a postmenopausal women | ||
653 | |a sedentary behaviour | ||
653 | |a aged | ||
653 | |a exercise | ||
653 | |a motivation | ||
653 | |a hepatoma | ||
653 | |a myokine | ||
653 | |a decorin | ||
653 | |a walking distance | ||
653 | |a survival | ||
653 | |a muscle strength | ||
653 | |a resistance training | ||
653 | |a randomized controlled trial | ||
653 | |a nutritional status | ||
653 | |a nutritional screening tools | ||
653 | |a hospitalized older patients | ||
653 | |a resistance exercise training | ||
653 | |a muscle regulatory factors | ||
653 | |a deconditioning | ||
653 | |a skeletal muscle | ||
653 | |a elderly | ||
653 | |a hypertrophy | ||
653 | |a multimorbidity | ||
653 | |a polypathological patients | ||
653 | |a frailty | ||
653 | |a oxidative stress | ||
653 | |a telomere length | ||
653 | |a apoptosis | ||
653 | |a spirometry | ||
653 | |a urea | ||
653 | |a fatigue | ||
653 | |a respiratory system | ||
653 | |a skeletal muscles | ||
653 | |a lipids | ||
653 | |a transaminases | ||
653 | |a falls | ||
653 | |a resistance exercise | ||
653 | |a vibration | ||
653 | |a electrical stimulation | ||
653 | |a hip fracture | ||
653 | |a diagnosis | ||
653 | |a treatment | ||
653 | |a prevention | ||
653 | |a dual-energy X-ray absorptiometry | ||
653 | |a bisphosphonate | ||
653 | |a β-hydroxy-β-methylbutyrate | ||
653 | |a exercise intervention | ||
653 | |a fall risk | ||
653 | |a balance | ||
653 | |a anxiety | ||
653 | |a depression | ||
653 | |a sleep quality | ||
653 | |a type 2 diabetes | ||
653 | |a physical activity | ||
653 | |a muscle mass | ||
653 | |a protein intake | ||
653 | |a accelerometer | ||
653 | |a aerobic exercise training | ||
653 | |a mitochondria | ||
653 | |a endurance | ||
653 | |a fractures | ||
653 | |a ageing fractures | ||
653 | |a complications | ||
653 | |a recovery | ||
653 | |a rehabilitation | ||
653 | |a nutritional supplements | ||
653 | |a physical therapy | ||
653 | |a cognition | ||
653 | |a brain-body cross-talk | ||
653 | |a older persons | ||
653 | |a prevalence | ||
653 | |a physical functional performance | ||
653 | |a epidemiologic studies | ||
653 | |a aging | ||
653 | |a panoramic ultrasound | ||
653 | |a echogenicity | ||
653 | |a specific force | ||
653 | |a isokinetic dynamometry | ||
653 | |a muscle quality | ||
653 | |a strength | ||
653 | |a older adults | ||
653 | |a diagnostic criteria | ||
653 | |a clinical | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3963 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76517 |7 0 |z DOAB: description of the publication |